Ensign Peak Advisors’s Core Laboratories CLB Stock Holding History

Ensign Peak Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,266	Closed	-$165K	–	1872
2022 Q3	$165K	Sell	12,266 -4,130	-25%	-$69.6K	﹤0.01%	1942
2022 Q2	$325K	Hold	16,396	–	–	﹤0.01%	1642
2022 Q1	$519K	Hold	16,396	–	–	﹤0.01%	1539
2021 Q4	$366K	Sell	16,396 -116,710	-88%	-$3.04M	﹤0.01%	1742
2021 Q3	$3.69M	Hold	133,106	–	–	0.01%	782
2021 Q2	$5.18M	Hold	133,106	–	–	0.01%	637
2021 Q1	$3.83M	Hold	133,106	–	–	0.01%	746
2020 Q4	$3.53M	Sell	133,106 -8,000	-6%	-$163K	0.01%	754
2020 Q3	$2.15M	Hold	141,106	–	–	0.01%	929
2020 Q2	$2.87M	Hold	141,106	–	–	0.01%	787
2020 Q1	$1.46M	Buy	141,106 +98,300	+230%	+$2.75M	﹤0.01%	983
2019 Q4	$1.61M	Buy	+42,806	New	+$1.92M	﹤0.01%	1154

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Ensign Peak Advisors's CLB Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Core Laboratories (CLB) in Q4 2022, closing a stake of 12,266 shares — an estimated $165K sold.

Ensign Peak Advisors first reported a position in CLB in Q4 2019 and held it in 12 quarters. The position peaked at $5.18M in Q2 2021. 161 funds tracked by Wall St. Rank hold CLB as of Q4 2022.

Ensign Peak Advisors reported no remaining Core Laboratories position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 12,266 Core Laboratories shares in Q4 2022, an estimated $165K.
Ensign Peak Advisors first reported a position in Core Laboratories in Q4 2019 and held it in 12 quarters.
Ensign Peak Advisors's Core Laboratories position peaked at $5.18M in Q2 2021.
161 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.